| 826 |
2026-08-12 |
PT. SUNTHI SEPURI |
ISX02-4 | Insert Ativan Common |
11,200 |
exp |
On Progress |
|
| 825 |
2026-08-12 |
PT. SUNTHI SEPURI |
LFA02 | Leaflet Ativan |
11,200 |
exp |
On Progress |
|
| 824 |
2026-08-11 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
Lft.01.141 | Leaflet Eterlox (01) |
24,000 |
exp |
On Progress |
|
| 823 |
2026-08-11 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/02/386 | LFT Nospirinal 80 (02) |
28,800 |
exp |
On Progress |
|
| 822 |
2026-08-11 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
UB/00/968 | UB Quetvell 25 |
12,000 |
exp |
On Progress |
|
| 821 |
2026-08-10 |
PT. SUNTHI SEPURI |
LFA02 | Leaflet Ativan |
5,600 |
exp |
On Progress |
|
| 820 |
2026-08-10 |
PT. SUNTHI SEPURI |
ISX02-4 | Insert Ativan Common |
5,600 |
exp |
On Progress |
|
| 819 |
2026-08-10 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/03/735 | LFT Angintriz MR (03) |
32,000 |
exp |
On Progress |
|
| 818 |
2026-08-06 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/01/1060 | LFT Metphar XR (01) |
3,400 |
exp |
On Progress |
|
| 817 |
2026-08-06 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT.02.110 | LFT Nimodipine Infus (02) |
4,400 |
exp |
On Progress |
|